75 citations
,
February 2016 in “The Journal of Sexual Medicine”
This review highlights the efficacy of transdermal testosterone therapy in improving sexual function in women with hypoactive sexualdesire disorder, though approved formulations and long-term safety data are limited.
14 citations
,
January 2001 in “Primary Care Update for Ob/gyns”
This review discusses the challenges in addressing femalesexual dysfunction, focusing on the complexities of femalesexual response, levels of dysfunction, clinical identification, and existing treatments, but presents no new clinical findings.
20 citations
,
April 2021 in “Journal of Womens Health”
This guideline provides evidence-based recommendations for prescribing testosterone therapy to women with hypoactive sexualdesire disorder, noting a moderate therapeutic benefit but highlighting limited data and regulatory challenges.
This study provides a guideline for the safe and effective use of testosterone in women with hypoactive sexualdesire disorder, recommending systemic transdermal testosterone for appropriate candidates while highlighting the importance of informed consent and monitoring due to unestablished long-term safety.
Finasteride and minoxidil are discussed as hair loss treatments, with mixed opinions on side effects like sexual dysfunction and mood changes. Some users report positive results, while others express concerns about potential risks and insufficient information.
The conversation discusses using a low dose of topical finasteride to achieve hair benefits with minimal systemic exposure. Users share experiences and opinions on dosing, systemic buildup, and side effects of both topical and oral finasteride.
The conversation discusses the effects of finasteride on libido, with the original poster experiencing a significant decrease in sexualdesire after starting the medication. Other users share similar experiences and suggest potential remedies, including Vitamin E supplementation and lifestyle changes like avoiding pornography.
The user has been using oral finasteride and minoxidil for 4 months and is seeing some hair regrowth, particularly in front of the crown. They experienced reduced sexualdesire as a side effect but are content with the progress in hair density.
Finasteride is seen as risky for men due to side effects like erectile dysfunction, while hormonal birth control for women is normalized despite its side effects. The discussion points out a double standard influenced by societal and gender norms.